HIGH-RISK NEUROBLASTOMA
Clinical trials for HIGH-RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH-RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests whether adding the drug naxitamab to standard chemotherapy is safe and effective for children and young adults newly diagnosed with high-risk neuroblastoma, an aggressive nerve cell cancer. Ten participants aged 1 to 21 will receive the combination and be monitor…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Shaare Zedek Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New scan could spot childhood cancer more clearly
Diagnosis Not yet recruitingThis study tests whether a new type of PET scan (18F-MFBG) can detect neuroblastoma tumors as accurately as the current standard scan (123I-MIBG). About 84 children and adults with newly diagnosed, high-risk neuroblastoma will receive both scans to compare results. If the new sca…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC